Search Results

Business

TaiGen Enters Exclusive License Agreement with Joincare for TG-1000 in China

TaiGen Biotechnology Company, Limited announces that they have signed an exclusive licensing agreement with Joincare Pharmaceutical Group Industry Co., Ltd., a top 10 China pharmaceutical company, to develop and commercialize TG-1000 in China.

March 22, 2023

·

3 min read

Drug Development

TaiGen Successfully Completes TG-1000 Phase III Study

TaiGen Biotechnology Company, Limited announces that the business partner, Joincare Pharmaceutical, has completed the unblinding of influenza antiviral TG-1000 phase III study.

April 17, 2024

·

2 min read

Fermion announces IND Approval of Non-Addictive Pain Relief Drug FZ008-145 by China NMPA

Guangzhou Fermion Technology Co., Ltd. has announced today that China National Medical Products Administration (NMPA) approved the Investigational New Drug (IND) application for its non-addictive pain relief drug FZ008-145.

January 10, 2024

·

2 min read

Business

Joincare to Build $157 Million Antibiotic Facility

August 22, 2012

·

1 min read

The Week in Review: Joincare to Invest $157 Million in Antibiotic Facility

August 27, 2012

·

1 min read

Inhaled Antibiotics Therapy Market: Bronchitis Segment to expand significantly

Inhaled drugs are an important part of treatment for chronic lung disease, as the medicine rapidly reaches the airways.

August 17, 2021

·

4 min read

Week In Review: China Pharma Financing Deals

February 1, 2016

·

1 min read

Using “Gutter Oil” to Make Antibiotics In China?

September 4, 2012

·

1 min read

Haibin Pharma Announces European Approval for Bulk Antibiotic

December 2, 2011

·

1 min read